> Who cares if pharmaceutical companies or any other business is slow to adopt the AI, the AI will capture that market entirely making those companies obsolete
It wouldn't because of things which are not of a technical nature. Trials for instance might take much longer than developing the drug. Or complying with whatever regulations of given industry which normally requires some heavy-lifting process which is normally run by humans.
It wouldn't because of things which are not of a technical nature. Trials for instance might take much longer than developing the drug. Or complying with whatever regulations of given industry which normally requires some heavy-lifting process which is normally run by humans.